Plasma chitotriosidase in lysosomal storage diseases

Clinica Chimica Acta

Volumn 387, Issue 1-2, 2008, Pages 165-167

  Isman, Ferruh ^a   Hobert, Judith A ^b   Thompson, Jerry N ^c   Natowicz, Marvin R ^a,b,d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Pathology and Laboratory Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOTRIOSIDASE;

CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GAUCHER DISEASE; HUMAN; LETTER; LYSOSOME STORAGE DISEASE; MAJOR CLINICAL STUDY; MALE; MUCOPOLYSACCHARIDOSIS; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; HEXOSAMINIDASES; HUMANS; LYSOSOMAL STORAGE DISEASES;

EID: 35748937664     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.07.019     Document Type: Letter

References (11)

1. Malaguarnera L. Chitotriosidase: the yin and yang. Cell Mol Life Sci 63 (2006) 3018-3029
2. Hollak C.E.M., van Weely S., van Oers M.H.J., and Aerts J.M.F.G. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93 (1994) 1288-1292
3. Baldellow A., Andria G., Campbell P.E., et al. Paediatric non-neuronopathic Gaucher disease: recommendations for treatment and monitoring. Eur J Pediatr 163 (2004) 67-75
4. Weinreb N.J., Aggio M.C., Andersson H.C., et al. Gaucher disease type I: revised recommendations on evaluations and monitoring for adult patients. Semin Hematol 41 suppl 5 (2004) 15-22
5. Guo Y., He W., Boer A.M., et al. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis 18 (1995) 717-722
6. Michelakakis H., Dimitriou E., and Labadaridis I. The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update. J Inherit Metab Dis 27 (2004) 705-706
7. Ries M., Schaefer E., Lührs T., et al. Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A/B and C. J Inherit Metab Dis 29 (2006) 647-652
8. Wajner A., Michelin K., Burin M.G., et al. Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease. Clin Biochem 40 (2007) 365-369
9. Vedder A.C., Cox-Brinkman J., Hollak C.E.M., et al. Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy. Molec Genet Metab 89 (2006) 239-244
10. Kornfeld S., and Sly W.S. I-cell disease and pseudo-Hurler polydystrophy: disorders of lysosomal enzyme phosphorylation and localization. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease (2001), McGraw-Hill, New York 3469-3482
11. Renkema G.H., Boot R.G., Strijland A., et al. Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase. Eur J Biochem 244 (1997) 279-285